Siemens and BT enter into a global partnership for identity and access management

SIEMENSSiemens Medical Solutions (Siemens Med) and BT (British Telecommunications) have signed a worldwide value-added reseller agreement for the provision of identity and access management services to global clients. BT has excellent international market access and Siemens Med is a globally active supplier of a leading identity and access management suite. The new partnership consolidates the existing, successful collaborative relationship that the two companies have enjoyed for many years.

With its DirX products, Siemens offers a fully integrated identity and access management product suite. As the sole manufacturer, Siemens is able to combine its DirX products, professional services and technology into a complete solution, which also includes smartcards and physical and logical access. The system offers outstanding flexibility in the area of administration, particularly in the automated creation of user accounts and granting of associated access rights. DirX products offer leading-edge technology in terms of scalability, reliability and availability. DirX identity and access management also allows simple and effective integration with SAP systems, such as SAP Netweaver. These characteristics were decisive factors in BT's decision to collaborate with Siemens.

BT will use Siemens DirX products in client projects, which will thus benefit from BT's long-standing practical experience and international expertise in the consultancy, designing and integration of complex identity and access management (IAM) solutions. It will focus in particular on the efficiency of business processes, fulfilment of compliance criteria and advising customers on organisational aspects. Using project start-up resources such as the "Identity Management Healthcheck", BT systematically checks how well the company is prepared for IAM, so as to meet the expectations of all participants as realistically and efficiently as possible. The solution realised by BT can then be operated either on the customer’s site or as a hosted variant at one of BT’s secure data centres.

The experts from BT use worldwide standardised procedural models, methods and tools, so that BT is especially well-placed to undertake global projects. Customers can also, if they wish, take advantage of other offerings from BT’s service portfolio.

Ray Stanton, global head of BT’s business continuity, security and governance practice, said: "This ground breaking agreement underlines the ongoing strength and success of our relationship with Siemens, and brings to bear the combined skills and assets of our two organisations for the benefits of our clients in an area that is vital to the success and security of the modern organisation. BT is looking forward to developing a strong, fruitful, and long lasting partnership with Siemens, and ensuring that our customers receive a truly world class identity and access management service."

Doris Hermann, VP Security and Identity Management, Siemens AG Medical Solutions, said: "We are very excited by the opportunities to provide innovative and cost effective identity and access management services to our clients through this agreement with BT. We look forward to building on the strength of our existing relationships with BT and we are very confident that our global customers will appreciate and value our joint approach."

Thanks to this partnership, customers benefit from a unique combination: It gives them access to excellent consulting and managed services, and to a comprehensive, integrated identity and access management suite all from under one roof and backed up by worldwide support.

The partnership will be started in Germany, France, the UK and the US and then gradually expanded.

About Siemens Medical Solutions
Siemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting http://www.siemens.com/medical

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...